TRDA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.58%

Insider Buying (Last 12 Months): $119,271.76

Insider Selling (Last 12 Months): $1,280,746.80

Entrada Therapeutics Insider Trading History Chart

Entrada Therapeutics Share Price & Price History

^$12.15

▲ +0.24 (2.02%)

As of 04/19/2024 01:00 AM ET

Days: 30 | 90 | 365

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Entrada Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2024	Peter S Kim	Director	Buy	2,600	$13.57	$35,282.00	62,936
3/28/2024	Peter S Kim	Director	Buy	1,512	$13.75	$20,790.00	60,336
3/25/2024	Peter S Kim	Director	Buy	3,180	$13.36	$42,484.80	56,074
3/21/2024	Peter S Kim	Director	Buy	704	$13.24	$9,320.96	49,776
3/19/2024	Peter S Kim	Director	Buy	900	$12.66	$11,394.00	47,944
2/15/2024	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	243,279
1/16/2024	Dipal Doshi	CEO	Sell	1,000	$15.99	$15,990.00	244,279
12/26/2023	Kory James Wentworth	CFO	Sell	94	$16.67	$1,566.98	49,571
12/22/2023	Kory James Wentworth	CFO	Sell	10,206	$15.69	$160,132.14	49,571
12/20/2023	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	245,279
11/13/2023	Dipal Doshi	CEO	Sell	1,000	$16.23	$16,230.00	246,279
10/17/2023	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	247,279
9/13/2023	Dipal Doshi	CEO	Sell	1,000	$15.00	$15,000.00	248,279
9/6/2023	Kory James Wentworth	CFO	Sell	950	$13.48	$12,806.00	49,571
9/6/2023	Nathan J Dowden	COO	Sell	972	$13.47	$13,092.84	48,168
9/6/2023	Nerissa Kreher	Insider	Sell	892	$13.48	$12,024.16	40,037
8/14/2023	Dipal Doshi	CEO	Sell	1,000	$15.67	$15,670.00	201,069
8/4/2023	Nerissa Kreher	Insider	Sell	6,898	$14.14	$97,537.72	27,130
8/2/2023	Nerissa Kreher	Insider	Sell	10,348	$15.19	$157,186.12	27,130
7/11/2023	Kory James Wentworth	CFO	Sell	3,884	$18.00	$69,912.00	36,747
7/10/2023	Natarajan Sethuraman	Insider	Sell	3,026	$18.00	$54,468.00	168,299
7/10/2023	Nathan J Dowden	COO	Sell	3,200	$18.00	$57,600.00	39,273
6/22/2023	Nathan J Dowden	COO	Sell	7,097	$16.02	$113,693.94	42,473
6/21/2023	Kory James Wentworth	CFO	Sell	17,500	$15.01	$262,675.00	27,957
6/20/2023	Nathan J Dowden	COO	Sell	8,885	$14.94	$132,741.90	49,570
4/27/2023	Dipal Doshi	CEO	Sell	2,000	$13.71	$27,420.00	202,069
4/17/2023	Dipal Doshi	CEO	Sell	2,092	$18.01	$37,676.92	204,069
4/17/2023	Natarajan Sethuraman	Insider	Sell	3,961	$18.00	$71,298.00	171,325
3/27/2023	Dipal Doshi	CEO	Sell	2,000	$14.72	$29,440.00	255,811
1/27/2023	Dipal Doshi	CEO	Sell	2,000	$12.00	$24,000.00	163,835
1/9/2023	Dipal Doshi	CEO	Sell	2,410	$15.02	$36,198.20	165,835
12/29/2022	Dipal Doshi	CEO	Sell	400	$15.01	$6,004.00	168,245
12/27/2022	Dipal Doshi	CEO	Sell	9,669	$15.02	$145,228.38	173,166
12/8/2022	Kory James Wentworth	CFO	Sell	4,550	$18.95	$86,222.50	16,509
12/5/2022	Kory James Wentworth	CFO	Sell	200	$18.05	$3,610.00	16,509
12/2/2022	Kory James Wentworth	CFO	Sell	2,910	$18.20	$52,962.00	16,509
11/28/2022	Dipal Doshi	CEO	Sell	2,000	$13.91	$27,820.00	182,835
10/31/2022	Nathan J Dowden	COO	Sell	2,100	$24.05	$50,505.00	45,283
10/27/2022	Dipal Doshi	CEO	Sell	2,000	$21.66	$43,320.00	184,835
10/25/2022	Nerissa Kreher	Insider	Sell	8,040	$20.88	$167,875.20	20,716
10/24/2022	Dipal Doshi	CEO	Sell	2,342	$19.30	$45,200.60	198,896
10/24/2022	Nathan J Dowden	COO	Sell	2,404	$19.30	$46,397.20	56,731
10/20/2022	Dipal Doshi	CEO	Sell	811	$18.01	$14,606.11	204,024
10/20/2022	Nathan J Dowden	COO	Sell	905	$18.07	$16,353.35	61,906
9/28/2022	Dipal Doshi	CEO	Sell	3,085	$15.23	$46,984.55	204,835
9/28/2022	Nerissa Kreher	Insider	Sell	3,122	$15.25	$47,610.50	20,716
9/26/2022	Dipal Doshi	CEO	Sell	3,083	$15.32	$47,231.56	212,339
9/26/2022	Nathan J Dowden	COO	Sell	1,544	$15.45	$23,854.80	62,811
9/26/2022	Nerissa Kreher	Insider	Sell	3,068	$15.33	$47,032.44	20,716
9/23/2022	Dipal Doshi	CEO	Sell	1,023	$15.07	$15,416.61	215,422
9/23/2022	Nathan J Dowden	COO	Sell	1,018	$15.07	$15,341.26	64,355
9/23/2022	Nerissa Kreher	Insider	Sell	939	$15.09	$14,169.51	20,716
9/21/2022	Dipal Doshi	CEO	Sell	3,402	$15.12	$51,438.24	216,445
9/21/2022	Nathan J Dowden	COO	Sell	3,275	$15.13	$49,550.75	65,373
9/21/2022	Nerissa Kreher	Insider	Sell	3,341	$15.08	$50,382.28	20,716
9/15/2022	Dipal Doshi	CEO	Sell	200	$15.04	$3,008.00	219,847
9/15/2022	Nathan J Dowden	COO	Sell	100	$15.01	$1,501.00	68,648
9/15/2022	Nerissa Kreher	Insider	Sell	106	$15.01	$1,591.06	20,716
9/9/2022	Nerissa Kreher	Insider	Sell	800	$15.07	$12,056.00	20,716
9/8/2022	Dipal Doshi	CEO	Sell	1,100	$15.16	$16,676.00	220,735
9/8/2022	Nathan J Dowden	COO	Sell	912	$15.15	$13,816.80	69,613
8/31/2022	Dipal Doshi	CEO	Sell	171	$12.00	$2,052.00	206,710
8/29/2022	Dipal Doshi	CEO	Sell	1,639	$12.88	$21,110.32	207,071
8/25/2022	Kory James Wentworth	CFO	Sell	1,551	$14.18	$21,993.18	10,986
8/23/2022	Kory James Wentworth	CFO	Sell	2,909	$13.09	$38,078.81	14,538
8/18/2022	Kory James Wentworth	CFO	Sell	200	$13.00	$2,600.00	20,221
8/16/2022	Kory James Wentworth	CFO	Sell	200	$13.00	$2,600.00	20,441
7/27/2022	Dipal Doshi	CEO	Sell	2,000	$12.00	$24,000.00	208,710
6/27/2022	Dipal Doshi	CEO	Sell	4,000	$12.00	$48,000.00	210,710
6/27/2022	Nathan J Dowden	COO	Sell	7,714	$13.00	$100,282.00	64,893
6/6/2022	Bros. Advisors Lp Baker	Major Shareholder	Buy	38,304	$6.41	$245,528.64	4,501,658
6/2/2022	Bros. Advisors Lp Baker	Major Shareholder	Buy	2,643	$5.82	$15,382.26	4,467,393
5/23/2022	Bros. Advisors Lp Baker	Major Shareholder	Buy	7,837	$5.99	$46,943.63	4,443,719
5/20/2022	Bros. Advisors Lp Baker	Major Shareholder	Buy	16,849	$5.84	$98,398.16	4,436,709
5/18/2022	Bros. Advisors Lp Baker	Major Shareholder	Buy	34,433	$6.00	$206,598.00	4,421,689
5/16/2022	Bros. Advisors Lp Baker	Major Shareholder	Buy	19,000	$5.83	$110,770.00	4,374,493
1/12/2022	John F. Crowley	Director	Buy	5,000	$9.71	$48,550.00

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad

Claim your free seat by clicking here now.

SEC Filings (Institutional Ownership Changes) for Entrada Therapeutics (NASDAQ:TRDA)

86.39% of Entrada Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Entrada Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Allspring Global Investments Holdings LLC	14,763	$0.21M	0.0%	+427.6%	0.044%
3/11/2024	Vanguard Group Inc.	1,065,166	$16.07M	0.0%	+4.4%	3.192%
3/5/2024	Wellington Management Group LLP	1,047,780	$15.81M	0.0%	+0.2%	3.140%
3/1/2024	Goldman Sachs Group Inc.	18,064	$0.27M	0.0%	+41.1%	0.054%
2/16/2024	Price T Rowe Associates Inc. MD	3,009,673	$45.42M	0.0%	+0.3%	9.019%
2/15/2024	Barclays PLC	31,730	$0.48M	0.0%	+434.9%	0.095%
2/15/2024	Vanguard Group Inc.	1,065,166	$16.07M	0.0%	+4.4%	3.192%
2/15/2024	Nuveen Asset Management LLC	80,510	$1.22M	0.0%	+9.7%	0.241%
2/15/2024	Oracle Alpha Inc.	12,500	$0.19M	0.2%	N/A	0.037%
2/15/2024	Price T Rowe Associates Inc. MD	3,009,673	$45.42M	0.0%	+0.3%	9.020%
2/14/2024	Royal Bank of Canada	7,085	$0.11M	0.0%	+90.3%	0.021%
2/14/2024	72 Investment Holdings LLC	172,600	$2.61M	11.6%	-66.1%	0.517%
2/13/2024	Northern Trust Corp	200,688	$3.03M	0.0%	-2.1%	0.601%
2/13/2024	Tower Research Capital LLC TRC	5,780	$87K	0.0%	+476.3%	0.017%
2/13/2024	Goldman Sachs Group Inc.	18,064	$0.27M	0.0%	+41.1%	0.054%
2/13/2024	California State Teachers Retirement System	14,210	$0.21M	0.0%	-5.3%	0.043%
2/9/2024	Franklin Resources Inc.	13,206	$0.20M	0.0%	N/A	0.040%
2/9/2024	UBS Group AG	22,476	$0.34M	0.0%	+68.9%	0.067%
2/6/2024	Charles Schwab Investment Management Inc.	151,358	$2.28M	0.0%	-2.5%	0.454%
2/6/2024	Swiss National Bank	23,000	$0.35M	0.0%	-8.7%	0.069%
1/30/2024	Strs Ohio	24,100	$0.36M	0.0%	+792.6%	0.072%
1/12/2024	SG Americas Securities LLC	11,714	$0.18M	0.0%	+27.7%	0.035%
12/18/2023	Vanguard Group Inc.	1,020,317	$16.12M	0.0%	+1.0%	3.058%
12/1/2023	Wellington Management Group LLP	1,045,652	$16.52M	0.0%	+2.6%	3.134%
11/30/2023	American Century Companies Inc.	138,798	$2.19M	0.0%	+460.0%	0.416%
11/24/2023	Deutsche Bank AG	10,038	$0.16M	0.0%	+18.0%	0.030%
11/15/2023	Redmile Group LLC	1,284,000	$20.29M	1.0%	-2.1%	3.848%
11/14/2023	Corton Capital Inc.	10,485	$0.17M	0.1%	-42.0%	0.031%
11/14/2023	California State Teachers Retirement System	15,007	$0.24M	0.0%	-13.3%	0.045%
11/13/2023	Northern Trust Corp	205,061	$3.24M	0.0%	+5.7%	0.615%
11/9/2023	Rhumbline Advisers	26,449	$0.42M	0.0%	+9.2%	0.080%
11/9/2023	Deutsche Bank AG	10,038	$0.16M	0.0%	+18.0%	0.030%
11/8/2023	Charles Schwab Investment Management Inc.	155,224	$2.45M	0.0%	+9.0%	0.468%
10/27/2023	Allspring Global Investments Holdings LLC	2,798	$44K	0.0%	N/A	0.008%
10/27/2023	TD Asset Management Inc	119,254	$1.88M	0.0%	+100.0%	0.359%
10/13/2023	SG Americas Securities LLC	9,174	$0.15M	0.0%	N/A	0.028%
9/21/2023	Barclays PLC	6,440	$97K	0.0%	-37.0%	0.019%
8/21/2023	California State Teachers Retirement System	17,301	$0.26M	0.0%	+79.6%	0.052%
8/16/2023	Nuveen Asset Management LLC	56,814	$0.86M	0.0%	+337.5%	0.171%
8/15/2023	Wells Fargo & Company MN	8,180	$0.12M	0.0%	+4,740.2%	0.025%
8/15/2023	Goldman Sachs Group Inc.	21,336	$0.32M	0.0%	-54.8%	0.064%
8/15/2023	Lazard Asset Management LLC	2,417	$36K	0.0%	N/A	0.007%
8/15/2023	Royal Bank of Canada	2,233	$34K	0.0%	N/A	0.007%
8/14/2023	Marshall Wace LLP	11,312	$0.17M	0.0%	-34.7%	0.034%
8/14/2023	State Street Corp	391,191	$5.92M	0.0%	+505.8%	1.176%
8/14/2023	Nuveen Asset Management LLC	56,814	$0.86M	0.0%	+337.5%	0.171%
8/11/2023	Nan Fung Group Holdings Ltd	49,082	$0.74M	0.5%	-33.3%	0.148%
8/11/2023	Credit Suisse AG	17,156	$0.26M	0.0%	+38.4%	0.052%
8/11/2023	BlackRock Inc.	1,405,806	$21.28M	0.0%	+563.2%	4.225%
8/11/2023	Ameritas Investment Partners Inc.	1,767	$27K	0.0%	N/A	0.005%
8/11/2023	The Manufacturers Life Insurance Company	56,149	$0.85M	0.0%	+17.7%	0.169%
8/11/2023	Geode Capital Management LLC	400,631	$6.07M	0.0%	+118.0%	1.204%
8/11/2023	JPMorgan Chase & Co.	16,650	$0.25M	0.0%	+95.0%	0.050%
8/11/2023	Northern Trust Corp	194,094	$2.94M	0.0%	+481.2%	0.583%
8/10/2023	MetLife Investment Management LLC	11,694	$0.18M	0.0%	N/A	0.035%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	10,874	$0.17M	0.0%	N/A	0.033%
8/10/2023	Russell Investments Group Ltd.	6,753	$0.10M	0.0%	N/A	0.020%
8/10/2023	Charles Schwab Investment Management Inc.	142,417	$2.16M	0.0%	+59.2%	0.429%
8/10/2023	Citigroup Inc.	6,663	$0.10M	0.0%	-89.3%	0.020%
8/9/2023	Swiss National Bank	25,200	$0.38M	0.0%	+6.3%	0.076%
8/4/2023	American International Group Inc.	10,299	$0.16M	0.0%	N/A	0.031%
8/3/2023	Barclays PLC	6,440	$97K	0.0%	-37.0%	0.019%
8/3/2023	Bank of New York Mellon Corp	66,387	$1.01M	0.0%	+433.7%	0.200%
7/31/2023	Strs Ohio	2,700	$40K	0.0%	N/A	0.008%
5/18/2023	JPMorgan Chase & Co.	8,540	$0.12M	0.0%	+12.5%	0.026%
5/16/2023	Susquehanna International Group LLP	196,513	$2.85M	0.0%	+75.8%	0.592%
5/16/2023	Jane Street Group LLC	73,898	$1.07M	0.0%	+408.8%	0.223%
5/16/2023	Geode Capital Management LLC	183,790	$2.67M	0.0%	+1.0%	0.554%
5/15/2023	Cubist Systematic Strategies LLC	4,160	$60K	0.0%	+927.2%	0.013%
5/15/2023	Price T Rowe Associates Inc. MD	2,983,863	$43.27M	0.0%	-1.0%	8.991%
5/12/2023	BlackRock Inc.	211,985	$3.07M	0.0%	+12.8%	0.639%
5/12/2023	Bank of America Corp DE	33,771	$0.49M	0.0%	+537.7%	0.102%
5/12/2023	HRT Financial LP	38,395	$0.56M	0.0%	N/A	0.116%
5/12/2023	Wellington Management Group LLP	1,014,453	$14.71M	0.0%	+0.4%	3.057%
5/11/2023	CHI Advisors LLC	56,374	$0.82M	0.2%	N/A	0.170%
5/11/2023	FMR LLC	531,408	$7.71M	0.0%	+5.5%	1.601%
5/11/2023	Citigroup Inc.	62,023	$0.90M	0.0%	+21.5%	0.187%
5/10/2023	Credit Suisse AG	12,399	$0.18M	0.0%	+40.7%	0.037%
5/10/2023	Swiss National Bank	23,700	$0.34M	0.0%	-10.6%	0.071%
5/9/2023	Y Intercept Hong Kong Ltd	10,188	$0.15M	0.0%	N/A	0.031%
2/24/2023	Natixis	26,186	$0.35M	0.0%	N/A	0.083%
2/15/2023	Jane Street Group LLC	14,524	$0.20M	0.0%	N/A	0.046%
2/15/2023	State of Wisconsin Investment Board	10,971	$0.15M	0.0%	N/A	0.035%
2/15/2023	Legal & General Group Plc	2,937	$40K	0.0%	N/A	0.009%
2/15/2023	Millennium Management LLC	39,894	$0.54M	0.0%	N/A	0.127%
2/15/2023	Morgan Stanley	24,886	$0.34M	0.0%	+136.3%	0.079%
2/14/2023	Price T Rowe Associates Inc. MD	3,014,377	$40.75M	0.0%	+1.4%	9.597%
2/14/2023	Susquehanna International Group LLP	111,797	$1.51M	0.0%	N/A	0.356%
2/14/2023	683 Capital Management LLC	10,355	$0.14M	0.0%	N/A	0.033%
2/13/2023	Charles Schwab Investment Management Inc.	88,970	$1.20M	0.0%	+1.3%	0.283%
2/13/2023	Natixis	26,186	$0.35M	0.0%	N/A	0.083%
2/13/2023	Barclays PLC	10,772	$0.15M	0.0%	+786.6%	0.034%
2/13/2023	Credit Suisse AG	8,811	$0.12M	0.0%	N/A	0.028%
2/13/2023	Geode Capital Management LLC	181,957	$2.46M	0.0%	+8.9%	0.579%
2/13/2023	JPMorgan Chase & Co.	7,593	$0.10M	0.0%	N/A	0.024%
2/10/2023	Bank of America Corp DE	5,296	$72K	0.0%	+33.5%	0.017%
2/9/2023	Citigroup Inc.	51,042	$0.69M	0.0%	+3,124.4%	0.163%
2/8/2023	Swiss National Bank	26,500	$0.36M	0.0%	N/A	0.084%
11/16/2022	Fred Alger Management LLC	17,955	$0.28M	0.0%	N/A	0.057%
11/15/2022	State Street Corp	33,294	$0.53M	0.0%	+10.3%	0.106%

Data available starting January 2016

Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, which include ENTR-601-44, which is in Phase I clinical trial for the treatment of Duchenne muscular dystrophy; and ENTR-701, which is in Phase 1/2 clinical trial for the treatment of myotonic dystrophy type 1. The company also offers ENTR-601-45 and ENTR-601-50, which are in preclinical trail for the treatment of Duchenne muscular dystrophy; and ENTR-501, an intracellular thymidine phosphorylase enzyme replacement therapy, which is in preclinical trail for the treatment of mitochondrial neurogastrointestinal encephalomyopathy. Entrada Therapeutics, Inc. has a strategic collaboration and license agreement with Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize ENTR-701. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $12.15

$11.81

$12.19

50 Day Range

MA: $13.34

$11.58

$15.17

52 Week Range

Now: $12.15

$10.62

$18.44

Volume

87,455 shs

Average Volume

78,835 shs

Market Capitalization

$408.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Entrada Therapeutics?: Entrada Therapeutics' top insider shareholders include:
Bros Advisors Lp Baker (Major Shareholder)
Dipal Doshi (CEO)
Natarajan Sethuraman (Insider)
Nathan J Dowden (COO)
Peter S Kim (Director)
Kory James Wentworth (CFO)
Nerissa Kreher (Insider)
Learn More about top insider investors at Entrada Therapeutics.
Who are the major institutional investors of Entrada Therapeutics?: Entrada Therapeutics' top institutional shareholders include:
Allspring Global Investments Holdings LLC — 0.04%
Learn More about top institutional investors of Entrada Therapeutics stock.
Which institutional investors are buying Entrada Therapeutics stock?: In the previous quarter, TRDA stock was purchased by institutional investors including:
Allspring Global Investments Holdings LLC
Within the previous year, these company insiders have bought Entrada Therapeutics stock:
Bros Advisors Lp Baker (Major Shareholder)
Dipal Doshi (CEO)
Learn More investors buying Entrada Therapeutics stock.